Summary
Updated Aug 30, 2026
James J. Ferguson III is Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS). 1 SEC Form 4 filing on record, dated 12 August 2026.
Recent Transactions
1Every recent SEC Form 4 transaction James J. Ferguson III has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies James J. Ferguson III files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Taylor Slingsby - $43.35M of MLYS open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $38.76M of MLYS open-market activity in the last 12 months
- Srinivas Akkaraju - $15.00M of MLYS open-market activity in the last 12 months
- Jon Congleton - $14.38M of MLYS open-market activity in the last 12 months
- Adam Scott Levy - $5.82M of MLYS open-market activity in the last 12 months
- David Malcom Rodman - $5.28M of MLYS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is James J. Ferguson III?
James J. Ferguson III is a corporate insider, tracked as Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has James J. Ferguson III submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of James J. Ferguson III's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow James J. Ferguson III and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
